Haleon Pakistan Limited's latest marketcap:
As of 07/05/2025, Haleon Pakistan Limited's market capitalization has reached $318.78 M. According to our data, Haleon Pakistan Limited is the 17245th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 318.78 M |
| Revenue (ttm) | 136.27 M |
| Net Income (ttm) | 18.3 M |
| Shares Out | 117.05 M |
| EPS (ttm) | 0.16 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 03/11/2025 |
| Earnings Date | 08/28/2025 |
Haleon Pakistan Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | rs318.78 M | -2.19% | 17245 |
| 12/31/2024 | rs94.54 B | 377.88% | 15670 |
| 12/29/2023 | rs19.78 B | 3.12% | 25547 |
| 12/30/2022 | rs19.19 B | -32.01% | 23431 |
| 12/31/2021 | rs28.22 B | -9.08% | 20229 |
| 12/31/2020 | rs31.03 B | 3.4% | 16983 |
| 12/31/2019 | rs30.02 B | 17.92% | 14954 |
| 12/31/2018 | rs25.45 B | -17.85% | 14370 |
| 12/29/2017 | rs30.99 B | 13196 |
Company Profile
About Haleon Pakistan Limited
Haleon Pakistan Limited is a leading manufacturer and marketer of consumer healthcare products, operating in Pakistan and exporting to multiple regions worldwide, including Africa, Australia, North America, Asia, the Middle East, and Europe.
Product Portfolio
The company specializes in a diverse range of healthcare products, including:
- Oral health (Sensodyne, paradontax)
- Pain relief (Panadol, Voltral Emulgel)
- Vitamins & mineral supplements (CaC-1000 Plus, Qalsium-D)
- Respiratory health (ENO, Hydrozole)
Key Brands
Haleon Pakistan's products are sold under well-known brands such as:
- Panadol
- Sensodyne
- ENO
- Voltral Emulgel
- T-Day
Global Reach
The company exports its products to key international markets, including the Philippines, Vietnam, and the East West Africa region.
Corporate Background
Originally established as GlaxoSmithKline Consumer Healthcare Pakistan Limited, the company rebranded to Haleon Pakistan Limited in January 2023. Incorporated in 2015 and headquartered in Karachi, Pakistan, it operates as a subsidiary of Glaxosmithkline Consumer Healthcare B.V.
Frequently Asked Questions
-
What is Haleon Pakistan Limited's (PSX-HALEON) current market cap?As of 07/05/2025, Haleon Pakistan Limited (including the parent company, if applicable) has an estimated market capitalization of $318.78 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Haleon Pakistan Limited (PSX-HALEON) rank globally by market cap?Haleon Pakistan Limited global market capitalization ranking is approximately 17245 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.